122 related articles for article (PubMed ID: 2150970)
1. Inhibition of MAO activity, 3H-imipramine binding, 3H-paroxetine binding and 3H-5-HT uptake by human cerebrospinal fluid.
Egashira T; Goto S; Murayama F; Yamanaka Y
J Neural Transm Suppl; 1990; 32():447-56. PubMed ID: 2150970
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the existence of serotonin uptake inhibitor-like substances in human cerebrospinal fluid.
Goto S; Egashira T; Yamanaka Y
Jpn J Pharmacol; 1991 Jul; 56(3):297-302. PubMed ID: 1832727
[TBL] [Abstract][Full Text] [Related]
3. Modulation of neuronal MAO activity, 5-HT uptake and imipramine binding by endogenous substances in dog cerebrospinal fluid.
Egashira T; Takano R; Yamanaka Y
Biochem Pharmacol; 1987 Jun; 36(11):1781-5. PubMed ID: 3034288
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat.
Graham D; Tahraoui L; Langer SZ
Neuropharmacology; 1987 Aug; 26(8):1087-92. PubMed ID: 2958720
[TBL] [Abstract][Full Text] [Related]
5. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
Plenge P; Mellerup ET; Laursen H
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
[TBL] [Abstract][Full Text] [Related]
6. Characterization of [3H]paroxetine binding in rat brain.
Marcusson JO; Bergström M; Eriksson K; Ross SB
J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
[TBL] [Abstract][Full Text] [Related]
7. Characterization of [3H]paroxetine binding to rat cortical membranes.
Habert E; Graham D; Tahraoui L; Claustre Y; Langer SZ
Eur J Pharmacol; 1985 Nov; 118(1-2):107-14. PubMed ID: 2935409
[TBL] [Abstract][Full Text] [Related]
8. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes.
Mellerup ET; Plenge P
Psychopharmacology (Berl); 1986; 89(4):436-9. PubMed ID: 2944152
[TBL] [Abstract][Full Text] [Related]
9. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin.
Gulati A; Arora RC; Crayton J
Eur J Pharmacol; 1993 Feb; 231(2):151-6. PubMed ID: 8453971
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.
Hrdina PD; Foy B; Hepner A; Summers RJ
J Pharmacol Exp Ther; 1990 Jan; 252(1):410-8. PubMed ID: 2137177
[TBL] [Abstract][Full Text] [Related]
11. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
[TBL] [Abstract][Full Text] [Related]
12. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
Graham D; Esnaud H; Habert E; Langer SZ
Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
14. High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
Hashimoto K; Goromaru T
Neuropharmacology; 1991 Feb; 30(2):113-7. PubMed ID: 2030818
[TBL] [Abstract][Full Text] [Related]
15. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.
Bäckström I; Bergström M; Marcusson J
Brain Res; 1989 May; 486(2):261-8. PubMed ID: 2525060
[TBL] [Abstract][Full Text] [Related]
16. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.
Plenge P; Mellerup ET
Eur J Pharmacol; 1985 Dec; 119(1-2):1-8. PubMed ID: 2935414
[TBL] [Abstract][Full Text] [Related]
17. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
Marcusson JO; Bäckström IT; Ross SB
Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
[TBL] [Abstract][Full Text] [Related]
18. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
Mellerup ET; Plenge P; Engelstoft M
Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
[TBL] [Abstract][Full Text] [Related]
19. Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro.
Goto S; Egashira T; Wada Y; Takayama F; Yamanaka Y
Jpn J Pharmacol; 1996 Aug; 71(4):291-8. PubMed ID: 8886926
[TBL] [Abstract][Full Text] [Related]
20. [3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments.
Cheetham SC; Viggers JA; Slater NA; Heal DJ; Buckett WR
Neuropharmacology; 1993 Aug; 32(8):737-43. PubMed ID: 8413837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
